Preview Mode Links will not work in preview mode

Jan 14, 2022

Featuring perspectives from Drs. Carey Anders, Virginia Borges, Sara Hurvitz and Ian Krop, moderated by Dr. Lisa Carey, including the following topics:

  • Considerations in the care of patients with HER2-positive localized breast cancer (BC) (0:00)
  • Optimizing the management of HER2-positive metastatic BC (23:19)
  • Treatment...


Jan 14, 2022

Featuring perspectives from Drs. Aditya Bardia, Kevin Kalinsky and Joyce O’Shaughnessy, moderated by Dr. Erika Hamilton, including the following topics:

  • Current Role of Genomic Classifiers to Inform Decision-Making for Patients with ER-Positive Localized Breast Cancer (0:00)
  • Emerging Treatment Strategies for Patients...


Jan 11, 2022

Featuring perspectives from Dr Hope Rugo, including the following topics:

  • Introduction: DESTINY-Breast03 Trial (0:00)
  • Case: A woman in her mid-60s with ER/PR-negative, HER2-positive metastatic breast cancer (mBC) — Raman Sood, MD (11:57)
  • Case: A woman in her late 60s with ER/PR-negative, HER2-positive mBC — Rohit...


Jan 8, 2022

Featuring perspectives from Drs Sara Hurvitz, Rita Nanda and Melinda Telli, moderated by Dr Hope Rugo, including the following topics:

  • Therapeutic strategies for patients with localized triple-negative breast cancer (TNBC) (0:00)
  • Current and future role of PARP inhibitors in metastatic TNBC (28:28)
  • Optimal integration...


Jan 4, 2022

Featuring perspectives from Dr Kevin Kalinsky, including the following topics:

  • Introduction (0:00)
  • Journal Club with Dr Kalinsky (1:08)
  • Case: A woman in her mid-60s with ER-positive, PR-negative, HER2-negative metastatic breast cancer (mBC) — Ann Partridge, MD, MPH (17:55)
  • Case: A woman in her early 30s with...